|
1
|
Loeser RF: Aging and osteoarthritis: The
role of chondrocyte senescence and aging changes in the cartilage
matrix. Osteoarthritis Cartilage. 17:971–979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldring MB: The role of the chondrocyte
in osteoarthritis. Arthritis Rheum. 43:1916–1926. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roughley PJ: Articular cartilage and
changes in arthritis: Noncollagenous proteins and proteoglycans in
the extracellular matrix of cartilage. Arthritis Res. 3:342–347.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aigner T and Kim HA: Apoptosis and
cellular vitality: Issues in osteoarthritic cartilage degeneration.
Arthritis Rheum. 46:1986–1996. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eyre D: Collagen of articular cartilage.
Arthritis Res. 4:30–35. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aizawa T, Kon T, Einhorn TA and
Gerstenfeld LC: Induction of apoptosis in chondrocytes by tumor
necrosis factor-alpha. J Orthop Res. 19:785–796. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fernandes JC, Martel-Pelletier J and
Pelletier JP: The role of cytokines in osteoarthritis
pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
|
|
8
|
Kapoor M, Martel-Pelletier J, Lajeunesse
D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in
the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Attur M, Al-Mussawir HE, Patel J, Kitay A,
Dave M, Palmer G, Pillinger MH and Abramson SB: Prostaglandin E2
exerts catabolic effects in osteoarthritis cartilage: Evidence for
signaling via the EP4 receptor. J Immunol. 181:5082–5088. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abramson SB: Osteoarthritis and nitric
oxide. Osteoarthritis Cartilage. 16 Suppl 2:S15–S20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burger D, Rezzonico R, Li JM, Modoux C,
Pierce RA, Welgus HG and Dayer JM: Imbalance between interstitial
collagenase and tissue inhibitor of metalloproteinases 1 in
synoviocytes and fibroblasts upon direct contact with stimulated T
lymphocytes: Involvement of membrane-associated cytokines.
Arthritis Rheum. 41:1748–1759. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang G, Li X, Li X, Wang L, Li J, Song X,
Chen J, Guo Y, Sun X, Wang S, et al: Traditional Chinese medicine
in cancer care: A review of case series published in the chinese
literature. Evid Based Complement Alternat Med. 2012:7510462012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Li X, Liu J, Ma L, Li X and Fønnebø
V: Traditional Chinese medicine in cancer care: A review of case
reports published in Chinese literature. Forsch Komplement Med.
18:257–263. 2011. View Article : Google Scholar
|
|
14
|
Kwon SW, Han SB, Park IH, Kim JM, Park MK
and Park JH: Liquid chromatographic determination of less polar
ginsenosides in processed ginseng. J Chromatogr A. 921:335–339.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SN, Ha YW, Shin H, Son SH, Wu SJ and
Kim YS: Simultaneous quantification of 14 ginsenosides in Panax
ginseng C.A. Meyer (Korean red ginseng) by HPLC-ELSD and its
application to quality control. J Pharm Biomed Anal. 45:164–170.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yun TK, Lee YS, Lee YH, Kim SI and Yun HY:
Anticarcinogenic effect of Panax ginseng C.A. Meyer and
identification of active compounds. J Korean Med Sci. 16
Suppl:S6–S18. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang KS, Kim HY, Baek SH, Yoo HH, Park JH
and Yokozawa T: Study on the hydroxyl radical scavenging activity
changes of ginseng and ginsenoside-Rb2 by heat processing. Biol
Pharm Bull. 30:724–728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nag SA, Qin JJ, Wang W, Wang MH, Wang H
and Zhang R: Ginsenosides as anticancer agents: In vitro and in
vivo activities, structure-activity relationships, and molecular
mechanisms of action. Front Pharmacol. 3:252012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee KY, Lee YH, Kim SI, Park JH and Lee
SK: Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase
activity via up-regulating p21Cip/WAF1 and down-regulating cyclin E
in SK-HEP-1 cells. Anticancer Res. 17A:1067–1072. 1997.
|
|
20
|
Shin YW, Bae EA and Kim DH: Inhibitory
effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an
oxazolone-induced mouse chronic dermatitis model. Arch Pharm Res.
29:685–690. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim TW, Joh EH, Kim B and Kim DH:
Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting
the binding of LPS to toll-like receptor-4 on macrophages. Int
Immunopharmacol. 12:110–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim EJ, Jung IH, Van Le TK, Jeong JJ, Kim
NJ and Kim DH: Ginsenosides Rg5 and Rh3 protect scopolamine-induced
memory deficits in mice. J Ethnopharmacol. 146:294–299. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kühn K, D'Lima DD, Hashimoto S and Lotz M:
Cell death in cartilage. Osteoarthritis Cartilage. 12:1–16. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jubb RW and Fell HB: The breakdown of
collagen by chondrocytes. J Pathol. 130:159–167. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rosenberg AE: Bones, joints, and soft
tissue tumorsRobbins Pathologic Basis of Disease. 6th edition.
Cotran RS, Kumar C and Collins T: WB Saunders; Philadelphia, PA:
pp. 12531999
|
|
26
|
Naito K, Watari T, Muta T, Furuhata A,
Iwase H, Igarashi M, Kurosawa H, Nagaoka I and Kaneko K:
Low-intensity pulsed ultrasound (LIPUS) increases the articular
cartilage type II collagen in a rat osteoarthritis model. J Orthop
Res. 28:361–369. 2010.PubMed/NCBI
|
|
27
|
Goldring MB, Otero M, Plumb DA, Dragomir
C, Favero M, El Hachem K, Hashimoto K, Roach HI, Olivotto E, Borzì
RM, et al: Roles of inflammatory and anabolic cytokines in
cartilage metabolism: Signals and multiple effectors converge upon
MMP-13 regulation in osteoarthritis. Eur Cell Mater. 21:202–220.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wetzel M, Li L, Harms KM, Roitbak T,
Ventura PB, Rosenberg GA, Khokha R and Cunningham LA: Tissue
inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal
cell death following mild ischemia. Cell Death Differ. 15:143–151.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hashimoto S, Nishiyama T, Hayashi S,
Fujishiro T, Takebe K, Kanzaki N, Kuroda R and Kurosaka M: Role of
p53 in human chondrocyte apoptosis in response to shear strain.
Arthritis Rheum. 60:2340–2349. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Del Carlo M Jr and Loeser RF: Nitric
oxide-mediated chondrocyte cell death requires the generation of
additional reactive oxygen species. Arthritis Rheum. 46:394–403.
2002. View Article : Google Scholar : PubMed/NCBI
|
